Using magnetic stimulation to reduce fatigue in multiple sclerosis
Official title: Neuromodulation of the Left Premotor Cortex With Transcranial Magnetic Stimulation to Alleviate Fatigue in Multiple Sclerosis - a Randomised Controlled Clinical Trial
Run by Danish Research Centre for Magnetic Resonance · NCT06569550 · Data updated 2026-11-12
This study is testing if a type of magnetic stimulation can help reduce fatigue in people with Relapsing-Remitting Multiple Sclerosis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Danish Research Centre for Magnetic Resonance Academic / other |
| Locations | 1 site (Hvidovre, Capital Region) |
| Status | Recruiting |
| Started | August 14, 2024 |
| Main results expected | January 21, 2027 |
| Study ends | February 21, 2027 |
| Registry record updated | September 22, 2026 |
| Trial ID | NCT06569550 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals diagnosed with Relapsing-Remitting Multiple Sclerosis who experience moderate to severe fatigue.
✕Probably not a fit
Patients with significant psychiatric disorders, recent MS relapses, or those currently receiving treatment for fatigue may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to determine if repetitive Transcranial Magnetic Stimulation (rTMS) of the left premotor cortex can alleviate fatigue in patients with Relapsing-Remitting Multiple Sclerosis. Participants will receive either real or sham rTMS for 30 minutes over five consecutive days, followed by assessments through questionnaires and brain scans to evaluate changes in fatigue levels and brain activity. The study seeks to understand the relationship between brain excitation and inhibition in relation to fatigue symptoms in these patients.
Why it matters
Potential benefit: If successful, this intervention could provide a new non-pharmacological treatment option for managing fatigue in patients with Multiple Sclerosis.
How similar studies have gone: While the approach of using rTMS for fatigue in MS is relatively novel, similar studies have shown promise in other neurological conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * A confirmed diagnosis of relapse-remitting or secondary progressive multiple sclerosis, according to most recent McDonald's criteria (Thompson et al., 2018). This diagnosis must not be more recent than 3 months * Must have fatigue as a complaint, and an FSMC score corresponding to at least moderate fatigue (\>53) * Stable MS medication for at least 3 months Exclusion Criteria: * Pregnancy, any subject with the potential to become pregnant must ensure against this (e.g. by taking oral contraceptives, or other high efficacy method) * MS Relapse or steroid treatment within 3 months prior to inclusion * Current treatment targeted towards fatigue, or previous if discontinued within 3 months prior to inclusion * History of neurologic disease or other significant medical conditions, aside from MS * EDSS \> 6.5 * Major psychiatric disorder, including current clinical depression. * Intake of medication that primarily acts on CNS or neurotransmission, except SSRI or SNRI * Pacemaker or other implanted electronic devices * Any intracranial metal * Any metallic implant incompatible with MR scanning * Claustrophobia * Either patient or their close relatives suffering from epilepsy * Current Drug or alcohol abuse
Where it's running
-
Danish Research Centre for Magnetic Resonance
Hvidovre, Capital Region, Denmark Recruiting
Study contacts
- Principal investigator: Hartwig R Siebner, MD, DMSc — Danish Research Centre for Magnetic Resonance, Copenhagen University Hospital Hvidovre & University of Copenhagen
- Study coordinator: Hartwig R Siebner, MD, DMSc
- Email: hartwig@drcmr.dk
- Phone: 3862 6541
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Remote Ischaemic Conditioning for Fatigue After Stroke 2
Aat least 12 weeks after stroke, adults with post-stroke fatigue will try a simple hand-arm cuff treatment at home to see if it helps reduce fatigue.
-
Micro-choice-based approach to fatigue management
A small study in Basel will test a new four-day group program using micro-choices to help people with fatigue from multiple causes see if it’s doable, acceptable, and may help daily functioning.
-
HBS-301 for Narcolepsy: daily wakefulness and sleepiness improvement in adults
This Phase 3 study tests HBS-301 vs placebo in adults with narcolepsy to see if it helps with daytime sleepiness, cataplexy, sleepiness, and fatigue.
-
See if Nuvastatic helps with cancer-related fatigue in colon cancer patients on first-line chemotherapy
This trial tests whether Nuvastatic can lessen fatigue in adults with colon cancer who are receiving their first round of chemotherapy, compared to placebo.
-
Balance and gait in multiple sclerosis: linking motion data to function
Researchers will see if precise motion measurements of balance and walking relate to everyday functional tests in adults with MS.
-
Relaxation and breathing techniques to help with breathlessness and tiredness in cancer patients in palliative care
This study tests whether progressive muscle relaxation or deep breathing exercises can reduce dyspnea and fatigue and improve self-care in adults with cancer receiving palliative care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.